Trial Information
Temporal Realistic Assessment of the Fungal Infection Incidence Across Canada for High Risk Subjects With Hematological Disease (TRAFIC)
Inclusion Criteria:
- To be eligible for study inclusion, the participant must have:
- A hematological malignancy requiring high dose chemotherapy with or without bone
marrow transplant
Exclusion Criteria:
- The participant is not eligible for study inclusion if:
- Their IFI is not related to hematological malignancies.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Incidence of non-Candida invasive fungal infections at each center
Outcome Description:
Determination of the incidence of non-Candida invasive fungal infections in high-risk participants across institutions in Canada
Outcome Time Frame:
365 days
Safety Issue:
No
Authority:
Canada: Ethics Review Committee
Study ID:
P07501
NCT ID:
NCT01254318
Start Date:
July 2013
Completion Date:
March 2016
Related Keywords:
- Mycoses
- Leukemia
- hematological malignancy
- fungal infection
- leukemia
- Hematologic Diseases
- Leukemia
- Mycoses